RespireRx Pharmaceuticals Inc (fka RSPI)

[gfp927z]

Blade, Concerning the Org-26576 ADHD Phase 2 results, as per the clinicaltrials.gov site, the 'final data collection date' is Jan '09, and the 'study completion date' is March '09.

Schering already has the Org-26576 Phase 1/2 Depression results (final data collection - August '08, study completion date - October '08). The ADHD trial had 60 patients, and Depression had 24 patients.